Merck & Co., Inc. - Common Stock (MRK)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MRK on NYSE
CUSIP
58933Y105
Type / Class
Equity / Common Stock
Shares outstanding
2.53B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.9B
Holdings value
$159B
% of all portfolios
0.135%
Grand Portfolio weight change
-0.008%
Number of holders
3242
Number of buys
1488
Number of sells
-1547
Average Value change %
-0.01%
Average buys %
+0.014%
Average sells %
-0.022%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Merck & Co., Inc. - Common Stock (MRK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.02% $21.5B 253M The Vanguard Group Feb 28, 2025

Institutional Holders of Merck & Co., Inc. - Common Stock (MRK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.9B $159B -$5.12B $83.93 3,242
2025 Q2 1.96B $155B +$1.48B $79.16 3,286
2025 Q1 1.94B $174B -$3.61B $89.76 3,390
2024 Q4 1.97B $196B +$4.61B $99.48 3,528
2024 Q3 1.91B $217B -$5.51B $113.56 3,429
2024 Q2 1.95B $242B +$5.25B $123.80 3,470
2024 Q1 1.91B $252B -$1.32B $131.95 3,447
2023 Q4 1.93B $210B +$4.92B $109.02 3,341
2023 Q3 1.88B $194B -$4.56B $102.95 3,145
2023 Q2 1.92B $221B +$647M $115.39 3,196
2023 Q1 1.9B $203B +$1.4B $106.39 3,110
2022 Q4 1.9B $211B +$3.03B $110.95 3,165
2022 Q3 1.88B $162B +$649M $86.12 2,939
2022 Q2 1.87B $170B +$4.68B $91.17 2,967
2022 Q1 1.83B $150B +$133M $82.05 2,903
2021 Q4 1.83B $140B +$146M $76.64 2,856
2021 Q3 1.83B $138B -$825M $75.11 2,609
2021 Q2 1.84B $143B -$268M $77.77 2,631
2021 Q1 1.84B $142B -$1.12B $77.09 2,641
2020 Q4 1.87B $153B -$709M $81.80 2,654
2020 Q3 1.87B $155B -$971M $82.95 2,528
2020 Q2 1.88B $146B -$622M $77.33 2,461
2020 Q1 1.89B $146B -$1.89B $76.94 2,441
2019 Q4 1.91B $174B +$120M $90.95 2,499
2019 Q3 1.92B $161B -$1.26B $84.18 2,279
2019 Q2 1.93B $162B +$572M $83.85 2,265
2019 Q1 1.96B $163B -$1.35B $83.17 2,257
2018 Q4 1.98B $151B -$883M $76.41 2,214
2018 Q3 1.98B $141B +$3.6B $70.94 2,027
2018 Q2 1.94B $118B -$3.74B $60.70 1,986
2018 Q1 2B $109B -$934M $54.47 1,958
2017 Q4 2.02B $113B -$1.11B $56.27 1,973
2017 Q3 2.03B $130B +$1.16B $64.03 1,884
2017 Q2 2.03B $130B -$1.15B $64.09 1,885
2017 Q1 2.04B $130B +$11.6B $63.54 1,897
2016 Q4 2.05B $120B -$1.97B $58.87 1,875
2016 Q3 2.06B $128B +$1.13B $62.41 1,768
2016 Q2 2.04B $118B +$79.7M $57.61 1,713
2016 Q1 2.04B $108B -$675M $52.91 1,692
2015 Q4 2.05B $108B -$2.1B $52.82 1,709
2015 Q3 2.09B $103B -$227M $49.39 1,621
2015 Q2 2.1B $120B -$261M $56.93 1,676
2015 Q1 2.1B $121B -$449M $57.48 1,664
2014 Q4 2.11B $120B -$265M $56.79 1,666
2014 Q3 2.11B $125B -$1.86B $59.28 1,571
2014 Q2 2.14B $124B -$1.58B $57.85 1,572
2014 Q1 2.18B $124B +$4.04B $56.77 1,551